Our Pipeline

Arium Biolabs is advancing a diverse pipeline of enzyme-based technologies designed to address critical needs in medicine and industry. Our lead therapeutic programs focus on engineered enzymes capable of neutralizing synthetic opioids and treating complex metabolic disorders, leveraging our deep expertise in protein design and computational modeling. In parallel, we are developing next-generation industrial biocatalysts optimized for high turnover, stability, and operational efficiency. Each program is built on our proprietary enzyme-engineering platform, which integrates machine learning, simulation, and rapid experimental validation. Together, these efforts position Arium Biolabs to deliver transformative solutions across healthcare, diagnostics, and industrial biotechnology.